Key statistics
As of last trade, Alto Neuroscience Inc (ANRO:NYQ) traded at 13.50, 70.67% above the 52 week low of 7.91 set on Aug 12, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 13.43 |
---|---|
High | 13.57 |
Low | 12.78 |
Bid | 13.44 |
Offer | 13.52 |
Previous close | 13.43 |
Average volume | 322.25k |
---|---|
Shares outstanding | 26.96m |
Free float | 23.43m |
P/E (TTM) | -- |
Market cap | 362.06m USD |
EPS (TTM) | -- |
Data delayed at least 15 minutes, as of Sep 20 2024 16:11 BST.
More ▼
- Alto Neuroscience Announces Peer-Reviewed Publication in the Journal of Clinical Psychiatry Demonstrating Baseline Cognitive Performance is Not a Moderator of Response to Standard-of-Care Antidepressants
- Alto Neuroscience to Participate in Upcoming Investor Conferences
- Alto Neuroscience Reports Second Quarter 2024 Financial Results and Recent Business Highlights
- Alto Neuroscience Receives Funding Award from Wellcome Trust to Accelerate Development of ALTO-100 in Bipolar Depression Leveraging Precision Psychiatry Approach
- Alto Neuroscience Announces Enrollment Completion in Phase 2b Study of ALTO-100 in Major Depressive Disorder
More ▼